Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1^−/− mice

References

• Deshaw M, Pirofski LA. Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. Clin Exp Immunol. 1995;99:425-32. doi:10.1111/j.1365-2249.1995.tb05568.x. PMID:7882565
   PubMed Web of Science ®Google Scholar
• Subramaniam K, French N, Pirofski LA. Cryptococcus neoformans-reactive and total immunoglobulin profiles of human immunodeficiency virus-infected and uninfected Ugandans. Clin Diagn Lab Immunol. 2005;12:1168-76. PMID:16210479
   PubMedGoogle Scholar
• Subramaniam K, Metzger B, Hanau LH, Guh A, Rucker L, Badri S, Pirofski LA. IgM(+) memory B cell expression predicts HIV-associated cryptococcosis status. J Infect Dis. 2009;200:244-51. doi:10.1086/599318. PMID:19527168
   PubMed Web of Science ®Google Scholar
• Jalali Z, Ng L, Singh N, Pirofski LA. Antibody response to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan in patients after solid-organ transplantation. Clin Vaccine Immunol. 2006;13:740-6. doi:10.1128/CVI.00139-06. PMID:16829610
   PubMed Web of Science ®Google Scholar
• Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev. 2004;197:179-91. doi:10.1111/j.0105-2896.2004.0109.x. PMID:14962195
   PubMed Web of Science ®Google Scholar
• Hart M, Steel A, Clark SA, Moyle G, Nelson M, Henderson DC, Wilson R, Gotch F, Gazzard B, Kelleher P. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol. 2007;178:8212-20. doi:10.4049/jimmunol.178.12.8212. PMID:17548660
   PubMed Web of Science ®Google Scholar
• Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9:235-45. doi:10.1038/nri2524. PMID:19319142
   PubMed Web of Science ®Google Scholar
• Hardy RR. B-1 B cell development. J Immunol. 2006;177:2749-54. doi:10.4049/jimmunol.177.5.2749. PMID:16920907
   PubMed Web of Science ®Google Scholar
• Choi YS, Dieter JA, Rothaeusler K, Luo Z, Baumgarth N. B-1 cells in the bone marrow are a significant source of natural IgM. Eur J Immunol. 2012;42:120-9. doi:10.1002/eji.201141890. PMID:22009734
   PubMed Web of Science ®Google Scholar
• Rohatgi S, Pirofski LA. Molecular characterization of the early B cell response to pulmonary Cryptococcus neoformans infection. J Immunol. 2012;189:5820-30. doi:10.4049/jimmunol.1201514. PMID:23175699
   PubMed Web of Science ®Google Scholar
• Szymczak WA, Davis MJ, Lundy SK, Dufaud C, Olszewski M, Pirofski LA. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection. MBio. 2013;4:e00265-13. doi:10.1128/mBio.00265-13. PMID:23820392
   PubMed Web of Science ®Google Scholar
• Subramaniam KS, Datta K, Quintero E, Manix C, Marks MS, Pirofski LA. The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol. 2010;184:5755-67. doi:10.4049/jimmunol.0901638. PMID:20404271
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Baumgarth N. Natural IgM and the Development of B Cell-Mediated Autoimmune Diseases. Crit Rev Immunol. 2016;36:163-77. doi:10.1615/CritRevImmunol.2016018175. PMID:27910766
   PubMed Web of Science ®Google Scholar
• Composto G, Gonzalez D, Bucknum A, Silberman D, Taylor J, Kozlowski M, Bloomfield T, Bartlett T, Riggs J. Peritoneal T lymphocyte regulation by macrophages. Immunobiology. 2011;216:256-64. doi:10.1016/j.imbio.2010.04.002. PMID:20488579
   PubMed Web of Science ®Google Scholar
• Szczepanik M, Akahira-Azuma M, Bryniarski K, Tsuji RF, Kawikova I, Ptak W, Kiener C, Campos RA, Askenase PW. B-1 B cells mediate required early T cell recruitment to elicit protein-induced delayed-type hypersensitivity. J Immunol. 2003;171:6225-35. doi:10.4049/jimmunol.171.11.6225. PMID:14634139
   PubMed Web of Science ®Google Scholar
• Bogsan CS, RR NeB, Palos MC, Mortara RA, Almeida SR, Lopes JD, Mariano M. B-1 cells are pivotal for in vivo inflammatory giant cell formation. Int J Exp Pathol. 2005;86:257-65. doi:10.1111/j.0959-9673.2005.00433.x. PMID:16045548
   PubMed Web of Science ®Google Scholar
• Weber GF, Chousterman BG, Hilgendorf I, Robbins CS, Theurl I, Gerhardt LM, Iwamoto Y, Quach TD, Ali M, Chen JW, et al. Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis. J Exp Med. 2014;211:1243-56. doi:10.1084/jem.20131471. PMID:24821911
   PubMed Web of Science ®Google Scholar
• Eschke M, Piehler D, Schulze B, Richter T, Grahnert A, Protschka M, Müller U, Köhler G, Höfling C, Rossner S, et al. A novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis. Eur J Immunol. 2015;45:3339-50. doi:10.1002/eji.201545689. PMID:26381487
   PubMed Web of Science ®Google Scholar
• Aguirre KM, Johnson LL. A role for B cells in resistance to Cryptococcus neoformans in mice. Infect Immun. 1997;65:525-30. PMID:9009308
   PubMed Web of Science ®Google Scholar
• Rivera J, Mukherjee J, Weiss LM, Casadevall A. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. J Immunol. 2002;168:3419-27. doi:10.4049/jimmunol.168.7.3419. PMID:11907100
   PubMed Web of Science ®Google Scholar
• Mora DJ, Fortunato LR, Andrade-Silva LE, Ferreira-Paim K, Rocha IH, Vasconcelos RR, Silva-Teixeira DN, Nascentes GA, Silva-Vergara ML. Cytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitis. PLoS One. 2015;10:e0120297. doi:10.1371/journal.pone.0120297. PMID:25799044
   PubMed Web of Science ®Google Scholar
• Zaragoza O, Casadevall A. Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance. Cell Microbiol. 2006;8:1862-76. doi:10.1111/j.1462-5822.2006.00753.x. PMID:16824038
   PubMed Web of Science ®Google Scholar
• Rivera J, Zaragoza O, Casadevall A. Antibody-mediated protection against Cryptococcus neoformans is dependent on B cells. Infect Immun. 2005;73:1141-50. doi:10.1128/IAI.73.2.1141-1150.2005. PMID:15664957
   PubMed Web of Science ®Google Scholar
• Capolunghi F, Rosado MM, Sinibaldi M, Aranburu A, Carsetti R. Why do we need IgM memory B cells? Immunol Lett. 2013;152:114-20. doi:10.1016/j.imlet.2013.04.007. PMID:23660557
   PubMed Web of Science ®Google Scholar
• Rachini A, Pietrella D, Lupo P, Torosantucci A, Chiani P, Bromuro C, Proietti C, Bistoni F, Cassone A, Vecchiarelli A. An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neofonnans in vitro and exerts therapeutic, anticryptococcal activity in vivo. Infection and Immunity. 2007;75:5085-94. doi:10.1128/IAI.00278-07. PMID:17606600
   PubMed Web of Science ®Google Scholar
• Rohatgi S, Pirofski LA. Host immunity to Cryptococcus neoformans. Future Microbiol. 2015;10:565-81. doi:10.2217/fmb.14.132. PMID:25865194
   PubMed Web of Science ®Google Scholar
• Almeida SR, Aroeira LS, Frymuller E, Dias MA, Bogsan CS, Lopes JD, Mariano M. Mouse B-1 cell-derived mononuclear phagocyte, a novel cellular component of acute non-specific inflammatory exudate. Int Immunol. 2001;13:1193-201. doi:10.1093/intimm/13.9.1193. PMID:11526100
   PubMed Web of Science ®Google Scholar
• Ghosn EE, Russo M, Almeida SR. Nitric oxide-dependent killing of Cryptococcus neoformans by B-1-derived mononuclear phagocyte. J Leukoc Biol. 2006;80:36-44. doi:10.1189/jlb.1005603. PMID:16670124
   PubMed Web of Science ®Google Scholar
• Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell. 1992;68:869-77. doi:10.1016/0092-8674(92)90030-G. PMID:1547488
   PubMed Web of Science ®Google Scholar
• Szymczak WA, Sellers RS, Pirofski LA. IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms. Am J Pathol. 2012;180:1547-59. doi:10.1016/j.ajpath.2011.12.038. PMID:22342846
   PubMed Web of Science ®Google Scholar
• Rivera J, Mukherjee J, Weiss LM, Casadevall A. Antibody efficacy in murine pulmonary Cryptococcus neoformans infection: a role for nitric oxide. J Immunol. 2002;168:3419-27. doi:10.4049/jimmunol.168.7.3419. PMID:11907100
   PubMed Web of Science ®Google Scholar
• Holodick NE, Zeumer L, Rothstein TL, Morel L. Expansion of B-1a Cells with Germline Heavy Chain Sequence in Lupus Mice. Front Immunol. 2016;7:108. doi:10.3389/fimmu.2016.00108. PMID:27047495
   PubMed Web of Science ®Google Scholar
• Feldmesser M, Casadevall A. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J Immunol. 1997;158:790-9. PMID:8992996
   PubMed Web of Science ®Google Scholar